Active Biotech AB presents exploratory data from ANYARA project

Posted on: Wed, 10 Feb 2010 07:27:03 EST


Symbols: ATVBF
Feb 10, 2010 (M2 EQUITYBITES via COMTEX) --

Biotechnology company Active Biotech AB (NASDAQ OMX Nordic:ACTI) said on Wednesday that it has presented exploratory data from its ANYARA project at the Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado.

The drug candidate ANYARA, using TTS technology, is currently in pivotal Phase III clinical trials for renal cell cancer.

Study results demonstrate that TTS therapy can be further enhanced by specifically modulating the immune response in this experimental model, Active Biotech said.

Comments on this story may be sent to admin@m2.com

For full details on (ATVBF) ATVBF. (ATVBF) has Short Term PowerRatings at TradingMarkets. Details on (ATVBF) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.